Literature DB >> 10818151

Role of founder cell deficit and delayed neuronogenesis in microencephaly of the trisomy 16 mouse.

T F Haydar1, R S Nowakowski, P J Yarowsky, B K Krueger.   

Abstract

Development of the neocortex of the trisomy 16 (Ts16) mouse, an animal model of Down syndrome (DS), is characterized by a transient delay in the radial expansion of the cortical wall and a persistent reduction in cortical volume. Here we show that at each cell cycle during neuronogenesis, a smaller proportion of Ts16 progenitors exit the cell cycle than do control, euploid progenitors. In addition, the cell cycle duration was found to be longer in Ts16 than in euploid progenitors, the Ts16 growth fraction was reduced, and an increase in apoptosis was observed in both proliferative and postmitotic zones of the developing Ts16 neocortical wall. Incorporation of these changes into a model of neuronogenesis indicates that they are sufficient to account for the observed delay in radial expansion. In addition, the number of neocortical founder cells, i.e., precursors present just before neuronogenesis begins, is reduced by 26% in Ts16 mice, leading to a reduction in overall cortical size at the end of Ts16 neuronogenesis. Thus, altered proliferative characteristics during Ts16 neuronogenesis result in a delay in the generation of neocortical neurons, whereas the founder cell deficit leads to a proportional reduction in the overall number of neurons. Such prenatal perturbations in either the timing of neuron generation or the final number of neurons produced may lead to significant neocortical abnormalities such as those found in DS.

Entities:  

Keywords:  NASA Discipline Cell Biology; Non-NASA Center

Mesh:

Year:  2000        PMID: 10818151      PMCID: PMC6772637     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  45 in total

1.  The distribution and fate of bromodeoxyuridine and bromodeoxycytidine in the mouse and rat.

Authors:  J P KRISS; L REVESZ
Journal:  Cancer Res       Date:  1962-02       Impact factor: 12.701

Review 2.  Methods for determining numbers of cells and synapses: a case for more uniform standards of review.

Authors:  R E Coggeshall; H A Lekan
Journal:  J Comp Neurol       Date:  1996-01-01       Impact factor: 3.215

3.  Decreased cyclin dependent kinase in brain of patients with Down syndrome.

Authors:  G Bernert; M Nemethova; M Herrera-Marschitz; N Cairns; G Lubec
Journal:  Neurosci Lett       Date:  1996-09-20       Impact factor: 3.046

Review 4.  Numbers, time and neocortical neuronogenesis: a general developmental and evolutionary model.

Authors:  V S Caviness; T Takahashi; R S Nowakowski
Journal:  Trends Neurosci       Date:  1995-09       Impact factor: 13.837

5.  Evidence for large-scale astrocyte death in the developing cerebellum.

Authors:  B K Krueger; J F Burne; M C Raff
Journal:  J Neurosci       Date:  1995-05       Impact factor: 6.167

6.  The unbiased estimation of number and sizes of arbitrary particles using the disector.

Authors:  D C Sterio
Journal:  J Microsc       Date:  1984-05       Impact factor: 1.758

7.  Early ontogeny of the secondary proliferative population of the embryonic murine cerebral wall.

Authors:  T Takahashi; R S Nowakowski; V S Caviness
Journal:  J Neurosci       Date:  1995-09       Impact factor: 6.167

8.  Glutamate as a hippocampal neuron survival factor: an inherited defect in the trisomy 16 mouse.

Authors:  L L Bambrick; P J Yarowsky; B K Krueger
Journal:  Proc Natl Acad Sci U S A       Date:  1995-10-10       Impact factor: 11.205

Review 9.  Genetic basis for a mouse model of Down syndrome.

Authors:  R H Reeves; J D Gearhart; J W Littlefield
Journal:  Brain Res Bull       Date:  1986-06       Impact factor: 4.077

10.  Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation.

Authors:  Y Gavrieli; Y Sherman; S A Ben-Sasson
Journal:  J Cell Biol       Date:  1992-11       Impact factor: 10.539

View more
  21 in total

1.  Differential modulation of proliferation in the neocortical ventricular and subventricular zones.

Authors:  T F Haydar; F Wang; M L Schwartz; P Rakic
Journal:  J Neurosci       Date:  2000-08-01       Impact factor: 6.167

Review 2.  Seeing beyond the average cell: branching process models of cell proliferation, differentiation, and death during mouse brain development.

Authors:  Hugh R MacMillan; Michael J McConnell
Journal:  Theory Biosci       Date:  2010-09-08       Impact factor: 1.919

3.  Modeling local and cross-species neuron number variations in the cerebral cortex as arising from a common mechanism.

Authors:  Diarmuid J Cahalane; Christine J Charvet; Barbara L Finlay
Journal:  Proc Natl Acad Sci U S A       Date:  2014-11-24       Impact factor: 11.205

4.  Down syndrome is accompanied by significantly reduced cortical grey-white matter tissue contrast.

Authors:  Anke Bletsch; Caroline Mann; Derek S Andrews; Eileen Daly; Giles M Y Tan; Declan G M Murphy; Christine Ecker
Journal:  Hum Brain Mapp       Date:  2018-06-08       Impact factor: 5.038

5.  The chromatin-remodeling protein ATRX is critical for neuronal survival during corticogenesis.

Authors:  Nathalie G Bérubé; Marie Mangelsdorf; Magdalena Jagla; Jackie Vanderluit; David Garrick; Richard J Gibbons; Douglas R Higgs; Ruth S Slack; David J Picketts
Journal:  J Clin Invest       Date:  2005-02       Impact factor: 14.808

6.  Abnormal microRNA expression in Ts65Dn hippocampus and whole blood: contributions to Down syndrome phenotypes.

Authors:  Jennifer Keck-Wherley; Deepak Grover; Sharmistha Bhattacharyya; Xiufen Xu; Derek Holman; Eric D Lombardini; Ranjana Verma; Roopa Biswas; Zygmunt Galdzicki
Journal:  Dev Neurosci       Date:  2011-10-27       Impact factor: 2.984

Review 7.  Advanced microscopic imaging methods to investigate cortical development and the etiology of mental retardation.

Authors:  Tarik F Haydar
Journal:  Ment Retard Dev Disabil Res Rev       Date:  2005

8.  Gene network disruptions and neurogenesis defects in the adult Ts1Cje mouse model of Down syndrome.

Authors:  Chelsee A Hewitt; King-Hwa Ling; Tobias D Merson; Ken M Simpson; Matthew E Ritchie; Sarah L King; Melanie A Pritchard; Gordon K Smyth; Tim Thomas; Hamish S Scott; Anne K Voss
Journal:  PLoS One       Date:  2010-07-16       Impact factor: 3.240

9.  Deficits in human trisomy 21 iPSCs and neurons.

Authors:  Jason P Weick; Dustie L Held; George F Bonadurer; Matthew E Doers; Yan Liu; Chelsie Maguire; Aaron Clark; Joshua A Knackert; Katharine Molinarolo; Michael Musser; Lin Yao; Yingnan Yin; Jianfeng Lu; Xiaoqing Zhang; Su-Chun Zhang; Anita Bhattacharyya
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-28       Impact factor: 11.205

10.  Mathematical modeling supports substantial mouse neural progenitor cell death.

Authors:  Michael J McConnell; Hugh R MacMillan; Jerold Chun
Journal:  Neural Dev       Date:  2009-07-14       Impact factor: 3.842

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.